Huang Y, Ji Q, Zhu Y, Fu S, Chen S, Chu L
Front Cell Dev Biol. 2022; 9:777989.
PMID: 35111753
PMC: 8801939.
DOI: 10.3389/fcell.2021.777989.
Oldstone M, Ware B, Horton L, Welch M, Aiolfi R, Zarpellon A
Proc Natl Acad Sci U S A. 2018; 115(33):E7814-E7823.
PMID: 30061383
PMC: 6099862.
DOI: 10.1073/pnas.1804674115.
Mizuno M, Tomizawa A, Ohno K, Jakubowski J, Sugidachi A
PLoS One. 2016; 11(4):e0154661.
PMID: 27128503
PMC: 4851362.
DOI: 10.1371/journal.pone.0154661.
Protti A, Fortunato F, Artoni A, Lecchi A, Motta G, Mistraletti G
Crit Care. 2015; 19:39.
PMID: 25757508
PMC: 4338849.
DOI: 10.1186/s13054-015-0762-7.
Feghhi S, Sniadecki N
Int J Mol Sci. 2012; 12(12):9009-30.
PMID: 22272117
PMC: 3257114.
DOI: 10.3390/ijms12129009.
The thrombotic potential of oral pathogens.
Kerrigan S, Cox D
J Oral Microbiol. 2011; 1.
PMID: 21523210
PMC: 3077004.
DOI: 10.3402/jom.v1i0.1999.
Unravelling the mechanism and significance of thrombin binding to platelet glycoprotein Ib.
Ruggeri Z, Zarpellon A, Roberts J, Mc Clintock R, Jing H, Mendolicchio G
Thromb Haemost. 2010; 104(5):894-902.
PMID: 20941453
PMC: 3810535.
DOI: 10.1160/TH10-09-0578.
Flow-induced beta-hairpin folding of the glycoprotein Ibalpha beta-switch.
Zou X, Liu Y, Chen Z, Cardenas-Jiron G, Schulten K
Biophys J. 2010; 99(4):1182-91.
PMID: 20713002
PMC: 2920744.
DOI: 10.1016/j.bpj.2010.05.035.
Platelet adhesion under flow.
Ruggeri Z
Microcirculation. 2009; 16(1):58-83.
PMID: 19191170
PMC: 3057446.
DOI: 10.1080/10739680802651477.
Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
Yago T, Lou J, Wu T, Yang J, Miner J, Coburn L
J Clin Invest. 2008; 118(9):3195-207.
PMID: 18725999
PMC: 2518822.
DOI: 10.1172/JCI35754.
Flow-induced structural transition in the beta-switch region of glycoprotein Ib.
Chen Z, Lou J, Zhu C, Schulten K
Biophys J. 2008; 95(3):1303-13.
PMID: 18441028
PMC: 2479615.
DOI: 10.1529/biophysj.108.132324.
Functional property of von Willebrand factor under flowing blood.
Sugimoto M, Miyata S
Int J Hematol. 2002; 75(1):19-24.
PMID: 11843285
DOI: 10.1007/BF02981974.
Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice.
Nieswandt B, Schulte V, Bergmeier W, Mokhtari-Nejad R, Rackebrandt K, Cazenave J
J Exp Med. 2001; 193(4):459-69.
PMID: 11181698
PMC: 2195902.
DOI: 10.1084/jem.193.4.459.
Old concepts and new developments in the study of platelet aggregation.
Ruggeri Z
J Clin Invest. 2000; 105(6):699-701.
PMID: 10727435
PMC: 377470.
DOI: 10.1172/JCI9604.
Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions.
Goto S, Ikeda Y, Saldivar E, Ruggeri Z
J Clin Invest. 1998; 101(2):479-86.
PMID: 9435321
PMC: 508588.
DOI: 10.1172/JCI973.
Functional platelets after storage in vitro for 15--21 days.
White J, Hagert K, Nipper J, Rao G
Am J Pathol. 1980; 101(3):613-34.
PMID: 7446709
PMC: 1903655.
Excessive blood loss during operation in the patient treated with propylthiouracil.
Ikeda S, SCHWEISS J
Can Anaesth Soc J. 1982; 29(5):477-80.
PMID: 7127182
DOI: 10.1007/BF03009412.
Disorders of platelet function: mechanisms, diagnosis and management.
Huebsch L, Harker L
West J Med. 1981; 134(2):109-27.
PMID: 7013276
PMC: 1272531.
The prostanoids in hemostasis and thrombosis: a review.
Smith J
Am J Pathol. 1980; 99(3):743-804.
PMID: 6992594
PMC: 1903705.
Platelet factor 4 is chemotactic for neutrophils and monocytes.
Deuel T, Senior R, Chang D, Griffin G, Heinrikson R, Kaiser E
Proc Natl Acad Sci U S A. 1981; 78(7):4584-7.
PMID: 6945600
PMC: 319837.
DOI: 10.1073/pnas.78.7.4584.
